Research is being conducted on the role of ferroptosis, pyroptosis, and necroptosis in cancer immunotherapy, particularly in melanoma. These regulated cell death pathways are being explored for their potential to inform innovative therapies, with studies examining their mechanisms, implications, and potential clinical applications. The findings may have implications for the development of new cancer treatments, although the specific outcomes and applications are still being investigated.